Nicotinamide riboside as a neuroprotective therapy for glaucoma – A randomized controlled trial

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Nicotinamide riboside as a neuroprotective therapy for glaucoma – A randomized controlled trial
Principal Investigator
Professor Leung, Kai Shun   (Principal Investigator (PI))
Co-Investigator(s)
Dr Kam Ka-wai   (Co-Investigator)
Dr Wan Kelvin Ho-nam   (Co-Investigator)
Dr Chan Poemen Pui-man   (Co-Investigator)
Duration
42
Start Date
2019-07-01
Completion Date
2024-06-04
Amount
1476400
Conference Title
Nicotinamide riboside as a neuroprotective therapy for glaucoma – A randomized controlled trial
Keywords
glaucoma, neuroprotection, nicotinamide riboside, optical coherence, retinal nerve fiber layer
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
06171076
Grant Type
Health and Medical Research Fund - Full Grant
Funding Year
2018
Status
Completed
Objectives
To compare the rates of retinal nerve fiber layer (RNFL) thinning in patients with glaucoma treated with nicotinamide riboside versus those treated with placebo over 24 months of follow-up.